Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 61,29 € (+4,57 %). La mediana es de 63,59 € (+8,50 %).
| Comprar |
16 |
| Mantener |
9 |
| Vender |
1 |
Noticias Ir al feed de noticias
Altria Group yields 6.4% and has outperformed the S&P 500 in 2026 despite mixed results
Altria Group has delivered total returns above 24% in 2026 while trading at about 12 times forward earnings and offering a 6.4% forward dividend yield. Q2 results showed 1.2% net revenue growth and GAAP EPS of $1.37, down 2.8% year‑over‑year and missing estimates. The company raised its dividend 4.7% and announced a contract manufacturing deal with Philip Morris, but faces long‑term risks from declining cigarette use and slower progress in smokeless product market share that could threaten future earnings and the dividend. Investors should weigh the attractive yield and recent performance against the potential for an earnings downturn. » Más en finance.yahoo.com
Altria sues FDA seeking overhaul of tobacco product review system
Altria filed suit in federal court in Lubbock asking the FDA to replace its tobacco product review process, saying the agency's backlog and failure to meet statutory 180-day decision deadlines have blocked products like On! nicotine pouches and allowed illicit competitors to gain market share. The complaint, joined by the Texas Food and Fuel Association, asks the court to set aside the current regime and force development of a new review system, noting even fast-track applications remained undecided past agency targets. Regulators and campaigners say the process protects public health, while tobacco firms have resorted to litigation, threats to launch unapproved products and intensive lobbying to prompt regulatory changes. » Más en finance.yahoo.com
Altria adds Steven Presley to its board of directors
Altria has appointed Steven W. Presley to its board of directors. Presley is currently CEO of Refresco Benelux and previously held senior roles at Nestlé, including executive vice president and CEO for the Americas and North America regions. He will serve on the committees for compensation and human capital, innovation, and finance. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | |
|---|---|---|
| Ingresos | 5354,52 M | 19,30 % |
| Beneficio bruto | 4008,66 M | 22,72 % |
| Beneficio neto | 2013,53 M | 0,20 % |
| EBITDA | 2824,9 M | 3,88 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 98,83 mil M € |
Número de acciones | 1669,74 M |
Máximo/mínimo de 52 semanas | 66,22 € - 47,00 € |
Rentabilidad por dividendo | 6,24 % |
Dividendos TTM | 3,66 € |
Próximo dividendo | 0,95 € |
Beta | 0,49 |
Ratio P/E | 14,53 |
Ratio PEG | -1,71 |
Ratio P/B | -43,17 |
Ratio P/S | 5,26 |
Perfil de la empresa
Die Altria Group, Inc. produziert und verkauft über ihre Tochtergesellschaften rauchbare und orale Tabakprodukte in den Vereinigten Staaten. Das Unternehmen bietet Zigaretten hauptsächlich unter der Marke Marlboro, Zigarren und Pfeifentabak hauptsächlich unter der Marke Black & Mild und feuchte rauchlose Tabakprodukte unter den Marken Copenhagen, Skoal, Red Seal und Husky sowie orale Nikotinbeutel an. Das Unternehmen verkauft seine Tabakprodukte hauptsächlich an Großhändler, einschließlich Distributoren, und große Einzelhandelsunternehmen, wie z. B. Ladenketten. Die Altria Group, Inc. wurde 1822 gegründet und hat ihren Hauptsitz in Richmond, Virginia.
| Nombre | Altria Group, Inc. |
| CEO | Salvatore Mancuso |
| Sede | Richmond,
va Estados Unidos |
| Sitio web | |
| Sector | Consumo básico |
| Industria | Tabaco |
| Salida a bolsa | 02/01/1962 |
| Empleados | 5900 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NYSE | MO |
XETRA | PHM7.DE |
Frankfurt | PHM7.F |
Düsseldorf | PHM7.DU |
Hamburg | PHM7.HM |
Milan | 1MO.MI |
London | 0R31.L |
SIX | MOUSD.SW |
München | PHM7.MU |
Wien | ALTR.VI |
Descubrir activos
Los accionistas de Altria Group, Inc. también invierten en los siguientes activos